MARKET

ERGO

ERGO

Entia Biosciences Inc
EXMKT
0.0002
NaN%
Closed 09:30 03/26 EDT
OPEN
--
PREV CLOSE
0.0002
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0002
52 WEEK LOW
0.0001
MARKET CAP
6.73K
P/E (TTM)
-0.0040
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ERGO last week (0317-0321)?
Weekly Report · 2d ago
Weekly Report: what happened at ERGO last week (0310-0314)?
Weekly Report · 03/17 10:20
Weekly Report: what happened at ERGO last week (0303-0307)?
Weekly Report · 03/10 10:21
Weekly Report: what happened at ERGO last week (0224-0228)?
Weekly Report · 03/03 10:21
Weekly Report: what happened at ERGO last week (0217-0221)?
Weekly Report · 02/24 10:21
Weekly Report: what happened at ERGO last week (0210-0214)?
Weekly Report · 02/17 10:19
Weekly Report: what happened at ERGO last week (0203-0207)?
Weekly Report · 02/10 10:16
Weekly Report: what happened at ERGO last week (0127-0131)?
Weekly Report · 02/03 10:18
More
About ERGO
Entia Biosciences, Inc. develops pharmaceutical-grade organic compounds, including a foundational compound called ErgoD2. The Company also develops and markets health-related nutraceuticals and cosmeceuticals. ErgoD2 is a pharmaceutical-grade organic compound created from whole foods that contain the micro-nutrients L-ergothioneine, an amino acid that has a transporter (SLC22A4) in every human being, and vitamin D2. ErgoD2 improves iron homeostasis and mitigates iron-related disorders presenting in anemia, chronic kidney disease and select neurodegenerative diseases. The Company's ErgoD2 formulations utilize organically cultivated specialty mushrooms available from various domestic and international suppliers. These mushroom-based products are generally regarded as safe (GRAS). The Company's market and scientific research has identified mushroom species and suppliers to provide the nutritional profiles for its ErgoD2 formulations.

Webull offers Entia Biosciences Inc stock information, including EXMKT: ERGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ERGO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ERGO stock methods without spending real money on the virtual paper trading platform.